๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Adenocarcinoma of the Pancreas

Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP NCT05268692Phase 2, Phase 31 site๐Ÿ“ Kochi Kochi University ยท Tests: GS, GnP VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites๐Ÿ“ Santa Rosa๐Ÿ“ Hartford๐Ÿ“ Washington D.C. VM Oncology, LLC ยท Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel NCT06483555Phase 1, Phase 21 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: Gemcitabine, Nab paclitaxel, Erlotinib, NALIRIFOX, Folfirinox NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC NCT06405490Phase 21 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Nanoliposomal Irinotecan+Oxaliplatin +Capecitabine+Cadonilimab Dose Escalation and Dose Expansion Study of GAS in Subjects With Metastatic Pancreatic Adenocarcinoma NCT06229496Phase 13 sites๐Ÿ“ Chiayi City๐Ÿ“ Kaohsiung City๐Ÿ“ Taoyuan Chang Gung Memorial Hospital ยท Tests: Gemcitabine 800mg/m2 + Nab-paclitaxel 100mg/m2 + S-1 (dose according to BSA), Gemcitabine 800mg/m2 + Nab-paclitaxel 125โ€ฆ Contribution of New Pancreatic MRI Sequences for the Evaluation of Tumor Response in Pancreatic Adenocarcinomas NCT06842303NA1 site๐Ÿ“ Vandล“uvre-lรจs-Nancy Central Hospital, Nancy, France ยท Tests: Magnetic resonance elastography (MRE)., High-resolution diffusion sequence in MRI A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC) NCT06673017Phase 19 sites๐Ÿ“ Newport Beach๐Ÿ“ Miami๐Ÿ“ Detroit PanTher Therapeutics ยท Tests: PTM-101 Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer NCT06782932Phase 1, Phase 21 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: AGEN2373, Balstilimab, Cyclophosphamide, GVAX, AGEN2373 (RP2D) DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer NCT06757244Phase 25 sites๐Ÿ“ Marseille๐Ÿ“ Nantes๐Ÿ“ Paris Hopital Foch ยท Tests: Dostarlimab, Vitamin D3 (Cholecalciferol), mFOLFIRINOX Treatment Regimen, LV5FU2 Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT06895031Phase 21 site๐Ÿ“ Beijing Guangzhou JOYO Pharma Co., Ltd ยท Tests: JYP0015 Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma NCT07491445Phase 382 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Los Angeles Revolution Medicines, Inc. ยท Tests: daraxonrasib, gemcitabine, nab-paclitaxel A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors NCT04895709Phase 1, Phase 247 sites๐Ÿ“ Clovis๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach Bristol-Myers Squibb ยท Tests: BMS-986340, BMS-936558-01, Docetaxel, Pumitamig A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring NCT07700992n/a1 site๐Ÿ“ Milan Universitร  Vita-Salute San Raffaele ยท Tests: PANXEON Efficacy of Fistulotomy for Biliary Cannulation NCT04037007NA1 site๐Ÿ“ Mexico City Coordinaciรณn de Investigaciรณn en Salud, Mexico ยท Tests: Fistulotomy - High experienced., Fistulotomy - Low experienced., Conventional (guidewire) cannulation- High experiencedโ€ฆ Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors NCT07261631Phase 19 sites๐Ÿ“ Princeton๐Ÿ“ Montreal๐Ÿ“ Odense C Novartis Pharmaceuticals ยท Tests: 68Ga-NNS309, 177Lu-DFC413 A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer NCT07324096NA1 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biospecimen Collection, Computed Tomography with Contrast, Electronic Health Record Review BBO-11818 in Adult Subjects With KRAS Mutant Cancer NCT06917079Phase 117 sites๐Ÿ“ Los Angeles๐Ÿ“ Sacramento๐Ÿ“ San Diego TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) ยท Tests: BBO-11818, Pembrolizumab, Platinum chemotherapy (cisplatin or carboplatin), Pemetrexed, Cetuximab Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC) NCT04926467Phase 21 site๐Ÿ“ Dallas Baylor Research Institute ยท Tests: Anakinra Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5) NCT06384560Phase 1, Phase 24 sites๐Ÿ“ Amsterdam๐Ÿ“ Maastricht๐Ÿ“ Nieuwegein Amsterdam UMC, location VUmc ยท Tests: Pembrolizumab, Folfirinox, SABR Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma NCT05688215Phase 1, Phase 21 site๐Ÿ“ Los Angeles Jonsson Comprehensive Cancer Center ยท Tests: Biospecimen Collection, Computed Tomography, Core Biopsy, Fluorouracil, Irinotecan Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma NCT07259317Phase 220 sites๐Ÿ“ Scottsdale๐Ÿ“ Los Angeles๐Ÿ“ Orange Corcept Therapeutics ยท Tests: Relacorilant, Nab-paclitaxel, Gemcitabine THE-0504 in Patients With Solid Tumors NCT07646106Phase 11 site๐Ÿ“ Rome Thena Biotech S.r.l. ยท Tests: THE-0504 Early Feasibility Clinical Investigation to Assess YntraDoseโ„ข as a Neoadjuvant Treatment for LA-PDAC NCT07155850NA2 sites๐Ÿ“ Roma๐Ÿ“ London BetaGlue Therapeutics SpA ยท Tests: Medical device containing Y-90 microspheres delivered intratumorally and percutaneously into the pancreas BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours NCT04421820Phase 1, Phase 228 sites๐Ÿ“ Santa Monica๐Ÿ“ Tampa๐Ÿ“ Edmonton Bold Therapeutics, Inc. ยท Tests: BOLD-100 ยฑ FOLFOX ยฑ Bevacizumab Chemotherapy (Arm VII), BOLD-100 in combination with FOLFOX Chemotherapy (Arms I-VI) Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma NCT07377045Phase 17 sites๐Ÿ“ Boston๐Ÿ“ Barcelona๐Ÿ“ Donostia / San Sebastian Oncomatryx Biopharma S.L. ยท Tests: OMTX705, Nab-paclitaxel + Gemcitabine, Tislelizumab (i.v. 200mg) Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1 NCT06649474NA1 site๐Ÿ“ Clermont-Ferrand University Hospital, Clermont-Ferrand ยท Tests: assess the serum HMGB1 concentrations before and after an oxaliplatin-based chemotherapy Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma NCT05825066Phase 22 sites๐Ÿ“ Charlotte๐Ÿ“ Winston-Salem Wake Forest University Health Sciences ยท Tests: Nab paclitaxel, Gemcitabine, Radiological Assessments, mFOLFIRINOX MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma NCT06648434Phase 11 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Zunsemetinib, mFOLFIRINOX A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07610798Phase 1, Phase 21 site๐Ÿ“ Guangzhou Shenzhen Ionova Life Sciences Co., Ltd. ยท Tests: INV-8989
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy